Related Experiment Video
Updated: Jun 27, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
The importance of clinical context in evaluating algorithmic fairness: insights from a medication adherence
Amrita Mukhopadhyay1,2, Yunan Zhao2, Rumi Chunara3
1Division of Cardiology, Department of Medicine, NYU School of Medicine, New York, NY 10016, United States.
AI algorithms may worsen health disparities. This study found that while accuracy was similar across groups, differing false positive and negative rates for medication nonadherence predictions could exacerbate inequities in certain clinical scenarios.
Area of Science:
- Health equity research
- Clinical informatics
- Artificial intelligence in healthcare
Background:
- Artificial intelligence (AI) algorithms risk exacerbating health disparities by misallocating resources.
- An algorithm predicting medication nonadherence in heart failure (HF) patients was evaluated for potential bias.
Purpose of the Study:
- To assess if an AI algorithm predicting HF medication nonadherence could worsen existing health disparities.
- To examine algorithm performance across socioeconomic and racial subgroups.
Main Methods:
- Retrospective study of 34,697 HF patients.
- Compared algorithm performance (accuracy, false positive/negative rates) between low/high neighborhood socioeconomic status (nSES) and Black/White patients.
- Applied results to hypothetical clinical use cases.
Main Results:
- Algorithm accuracy was similar across nSES and racial subgroups.
- Higher false positive rates for nonadherence in low nSES and Black patients.
- Lower false negative rates for nonadherence in Black patients compared to White patients.
- Worsening disparities were noted in use cases where false positives could negatively impact care prioritization.
Conclusions:
- Despite similar overall accuracy, differential false positive and negative rates can lead to AI algorithms worsening health inequities.
- Contextual evaluation of AI predictions within specific clinical use cases is crucial to prevent unintended harm and promote equitable care.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...